Close

Ratings by Needham & Company (Michael Matson)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
8/10/2022 Masimo Corp. MASI Maintain Buy
(N/A)
 
 
  Details
5/27/2022 Medtronic, Inc. MDT Downgrade Hold
(Buy)
99.44
(82.97)
-16.56% Details
5/6/2022 iRhythm Technologies IRTC Maintain Buy
(N/A)
 
 
  Details
5/4/2022 Masimo Corp. MASI Maintain Buy
(N/A)
 
 
  Details
2/24/2022 iRhythm Technologies IRTC Upgrade Buy
(Hold)
107.61
(126.50)
17.55% Details
2/22/2022 Medtronic, Inc. MDT Maintain Buy
(N/A)
 
 
  Details
2/18/2022 Masimo Corp. MASI Upgrade Buy
(Hold)
152.37
(137.24)
-9.93% Details
1/24/2022 Medtronic, Inc. MDT Maintain Buy
(N/A)
 
 
  Details
12/15/2021 Medtronic, Inc. MDT Maintain Buy
(N/A)
 
 
  Details
11/23/2021 Medtronic, Inc. MDT Maintain Buy
(N/A)
 
 
  Details
11/17/2021 Cardiovascular Systems CSII Downgrade Hold
(Buy)
26.00
(12.94)
-50.23% Details
9/23/2021 Cardiovascular Systems CSII Maintain Buy
(N/A)
 
 
  Details
8/24/2021 Medtronic, Inc. MDT Maintain Buy
(N/A)
 
 
  Details
6/21/2021 ResMed RMD Maintain Buy
(N/A)
 
 
  Details
6/14/2021 ResMed RMD Maintain Buy
(N/A)
 
 
  Details
5/27/2021 Medtronic, Inc. MDT Maintain Buy
(N/A)
 
 
  Details
3/16/2021 ResMed RMD Upgrade Buy
(Hold)
187.09
(271.80)
45.28% Details
2/4/2021 Cardiovascular Systems CSII Maintain Buy
(N/A)
 
 
  Details
11/5/2020 Cardiovascular Systems CSII Maintain Buy
(N/A)
 
 
  Details
9/11/2020 iRhythm Technologies IRTC New Coverage Hold
(N/A)
211.10
(107.61)
-49.02% Details
6/11/2020 Cardiovascular Systems CSII Upgrade Buy
(Hold)
33.01
(12.94)
-60.8% Details
4/20/2020 Masimo Corp. MASI Downgrade Hold
(Buy)
199.70
(137.24)
-31.28% Details
3/30/2020 Medtronic, Inc. MDT Downgrade Buy
(Strong Buy)
89.89
(82.97)
-7.7% Details
2/20/2020 Masimo Corp. MASI Maintain Buy
(N/A)
 
 
  Details
5/7/2019 Masimo Corp. MASI Maintain Buy
(N/A)
 
 
  Details
3/13/2019 Masimo Corp. MASI Maintain Buy
(N/A)
 
 
  Details
2/27/2019 Masimo Corp. MASI Maintain Buy
(Buy)
 
 
  Details
9/14/2018 Masimo Corp. MASI New Coverage Buy
(N/A)
118.94
(199.70)
67.9% Details